News & Insights2021-02-08T17:22:09-05:00

News & Insights

Impact, observations, and insights to advance translational intelligence

All
Trends & Insights
COVID-19 Data Initiative
Press Releases
Conferences & Events

Webinar 27 October: Advancing Clinical Sample Management with a Virtual Sample Repository

Conferences & Events, Trends & Insights|

Register for the webinar here

Title: Advancing Clinical Sample Management with a Virtual Sample Repository

Date: Wednesday, 27 October 2021

Time: 12:00 PM Eastern Daylight Time

Duration: 30 minutes

You’ll see how a virtual repository delivered via QuartzBio’s translational hub provides visibility into clinical sample status:

  • Sample visibility across studies, central labs, third party vendors, biorepositories, and disparate source systems
  • KPI dashboards that report sample status including collection, processing, testing, consent, expiration – while highlighting collection gaps and discrepancies.
  • Dynamic visualizations to quickly review expected vs actual sample status by patient, time point, and assay type

(more…)

Monitoring Consent Status With a Novel Virtual Repository

Trends & Insights|

October 8, 2021 — Sponsors are challenged to keep track of complex sample inventories, both on study and for samples collected as part of completed studies that might be later mined for translational research needs. We frequently hear that teams spend significant time manually cross-referencing spreadsheets of inventory data, to answer questions such as:

  • “How many whole blood samples with a particular mutation do we have across all phase I studies?”
  • “Can we report sample expiration status across all of our contracted biorepositories?”
  • “When we identify a sample of interest, how can we confirm consent status?”

(more…)

From Translational Teams to Biomarker Operations: The Cross-Functional Impact of a Fragmented Clinical Trial Data Ecosystem

Trends & Insights|

August 31, 2021 — Clinical samples are moving across an increasing number of physical/virtual locations and data is delivered in an expanding array of file formats as clinical trials become increasingly more complex and data rich (report).

Biospecimens are analyzed using a variety of assay technologies, each generating its own set of reportables, quality control metrics and data/file formats. Data is delivered through multiple, disconnected pipelines (Figure 1).

This complexity creates obstacles for many functional groups within sponsor organizations:

(more…)

Webinar On Demand: Transcending Biomarker Data Chaos

Conferences & Events, Trends & Insights|

Watch the webinar here

Title: Transcending Biomarker Data Chaos: How Integrating Disparate PK, Clinical & Exploratory Data Enables Deep Translational Insights

Duration: 30 minutes

You will see how teams unlock translational intelligence:

  • Navigate vast exploratory data – identify trends and data points of interest
  • Surface insights – analyze biomarker trends in collaborative dashboards across subject IDs, time points, response status, and treatment groups
  • Access data rapidly – point and click navigation to underlying data files to interrogate the raw data behind the summary values
  • Interrogate cross assay – map to a common data dictionary to enable rapid interrogation of trends across assay modalities: within and across studies

(more…)

How to Use Technology to Contextualize Biomarker Data Within Decades of Experimental Results for Intuitive Biological Insight Generation

Trends & Insights|

July 29, 2021 — Translational research teams producing large datasets from biomarker-rich trials quickly face the next challenge: generating actionable insights from their data.

As we described in a previous case study, we have been working with many teams to enable deep mechanistic insight generation from their biomarker data to aid in signature development for selecting patients, predicting therapeutic response, and informing key development decisions.

(more…)

Load More Posts